Xeris Biopharma Holdings, Inc. (0A8E.L)
USD 3.29
(-4.76%)
USD 3.29
(-4.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48.2 Million | -102.89 Million | -102.89 Million | -95.53 Million | -80.55 Million | -56.27 Million |
| Net Income | -62.25 Million | -94.66 Million | -94.66 Million | -122.72 Million | -91.14 Million | -60.08 Million |
| Depreciation & Amortization | 13.16 Million | 12.66 Million | 12.66 Million | 1.87 Million | 1.46 Million | 320 Thousand |
| Deferred income taxes | -1.24 Million | -1.42 Million | -1.42 Million | 1.11 Million | 536 Thousand | -414 Thousand |
| Stock-based compensation | 10.71 Million | 12.16 Million | 11.38 Million | 8.27 Million | 6.48 Million | 1.72 Million |
| Change in working capital | -6.29 Million | -35.15 Million | -35.15 Million | 11.85 Million | -2.79 Million | 1.6 Million |
| Other non-cash items | -2.28 Million | 3.51 Million | 3.51 Million | 961 Thousand | 3.1 Million | 560 Thousand |
| Investing Cash Flow | -6 Million | 34.46 Million | 34.46 Million | 97.96 Million | -27.4 Million | -68.26 Million |
| Investments in PPE | -2.26 Million | -524 Thousand | -524 Thousand | -1.08 Million | -377 Thousand | -1.51 Million |
| Acquisitions | - | - | 38.46 Million | 38.46 Million | 377 Thousand | - |
| Investment purchases | -43.74 Million | - | -43.02 Million | -43.02 Million | -101.77 Million | -68.85 Million |
| Sales/Maturities of investments | 40 Million | 34.98 Million | 34.98 Million | 103.6 Million | 74.74 Million | 2.1 Million |
| Other Investing Activities | -3.74 Million | 34.98 Million | 4.55 Million | -27.02 Million | -377 Thousand | -66.75 Million |
| Financing Cash Flow | -428 Thousand | 127.47 Million | 127.47 Million | 27.24 Million | 126.06 Million | 128.21 Million |
| Debt repayment | - | -43.49 Million | -43.49 Million | -25.08 Million | -25.08 Million | -34.66 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1 Million | -468 Thousand | -468 Thousand | -534 Thousand | -63 Thousand | - |
| Common Stock Issuance | 581 Thousand | 30 Million | 30 Million | 27 Million | 65.89 Million | 98.32 Million |
| Other Financing Activities | -1.00 | 288.48 Million | 141.43 Million | 50.95 Million | 180.96 Million | 29.88 Million |
| Accounts receivables | -8.36 Million | -13.37 Million | -13.37 Million | -6.23 Million | -2.18 Million | -1.67 Million |
| Accounts payables | 6.95 Million | -4.31 Million | -4.31 Million | 5.52 Million | -2.48 Million | -1.11 Million |
| Inventory | -14.8 Million | -7.46 Million | -7.46 Million | -7.41 Million | -5.14 Million | 4.04 Million |
| Other working capital | 9.91 Million | -9.99 Million | -9.99 Million | 19.98 Million | 7.01 Million | 345 Thousand |
| Cash at beginning of period | 121.96 Million | 67.27 Million | 67.27 Million | 37.59 Million | 19.51 Million | 42.04 Million |
| Cash at end of period | 67.44 Million | 126.31 Million | 126.31 Million | 67.27 Million | 37.59 Million | 45.71 Million |
| Capital Expenditure | -2.26 Million | -524 Thousand | -524 Thousand | -1.08 Million | -377 Thousand | -1.51 Million |
| Effect of forex changes on cash | 123 Thousand | - | -3000.00 | -3000.00 | -22 Thousand | - |
| Net cash flow / Change in cash | -54.51 Million | 59.04 Million | 59.04 Million | 29.67 Million | 18.07 Million | 3.67 Million |
| Free Cash Flow | -50.47 Million | -103.41 Million | -103.41 Million | -96.62 Million | -80.93 Million | -57.78 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 FY | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15 Million | -18.98 Million | -62.25 Million | -13.39 Million | -12.18 Million | -19.84 Million |
| Depreciation & Amortization | 3.15 Million | 3.21 Million | 13.16 Million | 3.25 Million | 3.35 Million | 3.36 Million |
| Deferred income taxes | 749 Thousand | 307 Thousand | -1.24 Million | -1.24 Million | 2.83 Million | -416 Thousand |
| Stock-based compensation | 4.23 Million | 3.76 Million | 10.71 Million | 2.76 Million | 2.45 Million | 2.92 Million |
| Change in working capital | -3.38 Million | -5.63 Million | -6.29 Million | 17.82 Million | -10.71 Million | 445 Thousand |
| Other non-cash items | 19.33 Million | 12.23 Million | -2.28 Million | -2.93 Million | -361 Thousand | -222 Thousand |
| Investing Cash Flow | 4.6 Million | -19.65 Million | -6 Million | 14.86 Million | 14.65 Million | 8.45 Million |
| Investments in PPE | -397 Thousand | -164 Thousand | -2.26 Million | -132 Thousand | -345 Thousand | -1.54 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -5 Million | -24.48 Million | -43.74 Million | - | - | - |
| Sales/Maturities of investments | 10 Million | 5 Million | 40 Million | 15 Million | 15 Million | 10 Million |
| Other Investing Activities | 5 Million | -19.48 Million | -3.74 Million | 15 Million | 15 Million | 10 Million |
| Financing Cash Flow | 659 Thousand | 35.19 Million | -428 Thousand | -49 Thousand | -72 Thousand | 556 Thousand |
| Debt repayment | - | -38.16 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -51 Thousand | -3.43 Million | -1 Million | -49 Thousand | -72 Thousand | -25 Thousand |
| Common Stock Issuance | 710 Thousand | 459 Thousand | 581 Thousand | -32 Thousand | - | 581 Thousand |
| Other Financing Activities | 710 Thousand | -11.37 Million | -1.00 | -1.18 Million | -72 Thousand | 556 Thousand |
| Accounts receivables | -5.02 Million | 1.78 Million | -8.36 Million | 6.76 Million | -15.74 Million | 635 Thousand |
| Accounts payables | -1.59 Million | -4.47 Million | 6.95 Million | -353 Thousand | 297 Thousand | 80 Thousand |
| Inventory | -2.26 Million | -2.33 Million | -14.8 Million | -1.4 Million | -2.15 Million | -7.43 Million |
| Other working capital | 5.49 Million | -613 Thousand | 9.91 Million | 12.81 Million | 6.88 Million | 7.16 Million |
| Cash at beginning of period | 62.69 Million | 67.44 Million | 121.96 Million | 46.14 Million | 50.59 Million | 55.33 Million |
| Cash at end of period | 57.6 Million | 62.69 Million | 67.44 Million | 67.44 Million | 50.56 Million | 50.59 Million |
| Capital Expenditure | -397 Thousand | -164 Thousand | -2.26 Million | -132 Thousand | -345 Thousand | -1.54 Million |
| Effect of forex changes on cash | - | - | 123 Thousand | 201 Thousand | - | - |
| Net cash flow / Change in cash | -5.08 Million | -4.75 Million | -54.51 Million | 21.3 Million | -27 Thousand | -4.73 Million |
| Free Cash Flow | -10.74 Million | -20.46 Million | -50.47 Million | 6.15 Million | -14.95 Million | -15.29 Million |
9916
EMBR
0716
SCRPF
RBTC
EXC